Key numbers
Market Cap 20M EUR
Sales 4M EUR
Net Income 800K EUR
EPS 0,11 EUR
P/E 27
Cash 3M EUR
LT Debt 0 EUR
Assets 17M EUR
Liabilities 3M EUR
Shares Outstanding 6,800,000
Float 3,800,000
Major investors
Company founder, executive 33% held in a family trust
Wegold Edelmetalle 10%
Resume: curasan AG has signed an agreement which provides Zimmer Dental Inc, Carlsbad, CA, (USA) with exclusive global distribution rights for Osbone®, Ceracell® and Osseolive® synthetic bone grafting products for regenerative dental applications....(entering US market with strong partner)
curasan Inc. has signed an exclusive supply agreement with TransCorp Spine Inc., Michigan, USA, for Cerasorb® Ortho block forms used to repair vertebral bone channels created during surgeries to decompress neural tissue in the spine.
Bottom line: first time profitable EBIT & EPS from product sales, no debt, assets are much bigger than liabilities, big market for products, very low market cap, high insider ownership...you decide.
Market Cap 20M EUR
Sales 4M EUR
Net Income 800K EUR
EPS 0,11 EUR
P/E 27
Cash 3M EUR
LT Debt 0 EUR
Assets 17M EUR
Liabilities 3M EUR
Shares Outstanding 6,800,000
Float 3,800,000
Major investors
Company founder, executive 33% held in a family trust
Wegold Edelmetalle 10%
Resume: curasan AG has signed an agreement which provides Zimmer Dental Inc, Carlsbad, CA, (USA) with exclusive global distribution rights for Osbone®, Ceracell® and Osseolive® synthetic bone grafting products for regenerative dental applications....(entering US market with strong partner)
curasan Inc. has signed an exclusive supply agreement with TransCorp Spine Inc., Michigan, USA, for Cerasorb® Ortho block forms used to repair vertebral bone channels created during surgeries to decompress neural tissue in the spine.
Bottom line: first time profitable EBIT & EPS from product sales, no debt, assets are much bigger than liabilities, big market for products, very low market cap, high insider ownership...you decide.
